Robert LeBoyer
Stock Analyst at Noble Financial
(0.04)
# 4,625
Out of 4,639 analysts
423
Total ratings
29.3%
Success rate
-12%
Average return
Main Sectors:
Stocks Rated by Robert LeBoyer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRB Nutriband | Reiterated: Buy | $15 | $3.16 | +375.44% | 10 | Aug 12, 2026 | |
| NNVC NanoViricides | Reiterated: Buy | $6 | $1.36 | +341.18% | 3 | Aug 11, 2026 | |
| NRSN NeuroSense Therapeutics | Reiterated: Buy | $9 | $0.48405 | +1,759.31% | 8 | Aug 11, 2026 | |
| GYRE Gyre Therapeutics | Reiterated: Buy | $20 | $6.88 | +190.70% | 11 | Aug 10, 2026 | |
| OCGN Ocugen | Reiterated: Buy | $12 | $1.40 | +760.22% | 43 | Aug 7, 2026 | |
| GOVX GeoVax Labs | Reiterated: Buy | $10 | $0.748 | +1,236.90% | 26 | Jul 29, 2026 | |
| CVKD Cadrenal Therapeutics | Reiterated: Buy | $45 | $1.86 | +2,319.35% | 17 | Jul 14, 2026 | |
| MAIA MAIA Biotechnology | Reiterated: Buy | $14 | $1.37 | +921.90% | 23 | Jul 9, 2026 | |
| UNCY Unicycive Therapeutics | Reiterated: Buy | $60 → $50 | $5.41 | +824.21% | 19 | Jul 1, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $10 | $3.73 | +168.10% | 21 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $16.40 | +174.39% | 9 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $10 | $1.10 | +813.24% | 28 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.04 | +1,059.42% | 5 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $6.10 | +31.15% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $37 | $12.01 | +208.08% | 30 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0821 | n/a | 5 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.53 | n/a | 24 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2541 | n/a | 36 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.102 | n/a | 3 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.65 | n/a | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $9 | $1.11 | n/a | 11 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.71 | $0.08 | n/a | 2 | Jun 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $20 | $3.50 | n/a | 10 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $27 | $0.0001 | n/a | 7 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $15 | $4.35 | n/a | 8 | Jan 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $3.88 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $14 | $1.91 | n/a | 7 | Jan 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $5.28 | n/a | 2 | Dec 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.14 | n/a | 6 | Dec 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.00001 | n/a | 5 | Nov 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $13.32 | n/a | 1 | Oct 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.7899 | n/a | 8 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $1.45 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.79 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.07 | n/a | 2 | Nov 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $17 → $1 | $32.60 | n/a | 2 | Apr 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.16 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 4 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.52 | n/a | 3 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.2301 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.719 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.49 | n/a | 2 | Feb 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $54 → $41 | $29.51 | n/a | 2 | Aug 5, 2016 |
Nutriband
Aug 12, 2026
Reiterated: Buy
Price Target: $15
Current: $3.16
Upside: +375.44%
NanoViricides
Aug 11, 2026
Reiterated: Buy
Price Target: $6
Current: $1.36
Upside: +341.18%
NeuroSense Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $9
Current: $0.48405
Upside: +1,759.31%
Gyre Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $6.88
Upside: +190.70%
Ocugen
Aug 7, 2026
Reiterated: Buy
Price Target: $12
Current: $1.40
Upside: +760.22%
GeoVax Labs
Jul 29, 2026
Reiterated: Buy
Price Target: $10
Current: $0.748
Upside: +1,236.90%
Cadrenal Therapeutics
Jul 14, 2026
Reiterated: Buy
Price Target: $45
Current: $1.86
Upside: +2,319.35%
MAIA Biotechnology
Jul 9, 2026
Reiterated: Buy
Price Target: $14
Current: $1.37
Upside: +921.90%
Unicycive Therapeutics
Jul 1, 2026
Reiterated: Buy
Price Target: $60 → $50
Current: $5.41
Upside: +824.21%
Eledon Pharmaceuticals
Jun 23, 2026
Reiterated: Buy
Price Target: $10
Current: $3.73
Upside: +168.10%
Jun 2, 2026
Reiterated: Buy
Price Target: $45
Current: $16.40
Upside: +174.39%
May 27, 2026
Reiterated: Buy
Price Target: $6 → $10
Current: $1.10
Upside: +813.24%
May 22, 2026
Reiterated: Buy
Price Target: $12
Current: $1.04
Upside: +1,059.42%
May 8, 2026
Reiterated: Buy
Price Target: $8
Current: $6.10
Upside: +31.15%
Mar 16, 2026
Reiterated: Buy
Price Target: $70 → $37
Current: $12.01
Upside: +208.08%
Jun 27, 2025
Rated: Hold
Price Target: n/a
Current: $0.0821
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.53
Upside: n/a
Feb 24, 2025
Rated: Hold
Price Target: n/a
Current: $0.2541
Upside: n/a
Jan 21, 2025
Rated: Hold
Price Target: n/a
Current: $0.102
Upside: n/a
Aug 16, 2022
Reiterated: Buy
Price Target: $5
Current: $4.65
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $8 → $9
Current: $1.11
Upside: n/a
Jun 1, 2022
Reiterated: Buy
Price Target: $0.71
Current: $0.08
Upside: n/a
May 14, 2021
Maintained: Buy
Price Target: $20 → $20
Current: $3.50
Upside: n/a
Feb 9, 2021
Maintained: Buy
Price Target: $18 → $27
Current: $0.0001
Upside: n/a
Jan 26, 2021
Maintained: Buy
Price Target: $6 → $15
Current: $4.35
Upside: n/a
Jan 25, 2021
Initiated Coverage: Buy
Price Target: $8
Current: $3.88
Upside: n/a
Jan 24, 2021
Maintained: Buy
Price Target: $6 → $14
Current: $1.91
Upside: n/a
Dec 28, 2020
Downgraded: Hold
Price Target: n/a
Current: $5.28
Upside: n/a
Dec 24, 2020
Maintained: Buy
Price Target: $6
Current: $1.14
Upside: n/a
Nov 12, 2020
Reiterated: Buy
Price Target: $8
Current: $0.00001
Upside: n/a
Oct 5, 2020
Downgraded: Hold
Price Target: n/a
Current: $13.32
Upside: n/a
May 28, 2020
Maintained: Buy
Price Target: $5
Current: $0.7899
Upside: n/a
Feb 18, 2020
Initiated Coverage: Buy
Price Target: $30
Current: $1.45
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $4.79
Upside: n/a
Nov 1, 2018
Rated: Hold
Price Target: n/a
Current: $1.07
Upside: n/a
Apr 10, 2018
Downgraded: Hold
Price Target: $17 → $1
Current: $32.60
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $1.16
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $9.52
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.2301
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $0.719
Upside: n/a
Feb 2, 2018
Rated: Hold
Price Target: n/a
Current: $2.49
Upside: n/a
Aug 5, 2016
Downgraded: Hold
Price Target: $54 → $41
Current: $29.51
Upside: n/a